Hindelang Michael, Zink Alexander, Knitza Johannes, Darkow Robert, Welcker Martin, Biedermann Tilo, May Susann, Muehlensiepen Felix
TUM School of Medicine and Health, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Pettenkofer School of Public Health, Munich, Germany.
BMC Health Serv Res. 2025 Jul 2;25(1):894. doi: 10.1186/s12913-025-13043-7.
BACKGROUND: Chronic urticaria (CU) is a complex and unpredictable skin condition that significantly affects patients’ quality of life. As the healthcare landscape increasingly integrates digital health technologies, understanding their perceived usefulness in CU management from both patient and physician perspectives is crucial. OBJECTIVE: This study investigates the acceptance, perceived usefulness, and potential barriers to using digital health services, such as medical apps and video consultations, among patients with CU and their healthcare providers. METHODS: A quantitative survey was conducted across multiple specialized centers, specialist clinics, and general practices, involving both patients and physicians. The study utilized standardized questionnaires to assess digital health literacy, technology readiness, and attitudes toward adopting digital health services in CU management. Descriptive and inferential statistics, including Fisher’s exact test, were employed to analyze the data. RESULTS: A substantial proportion of the 121 surveyed patients and 101 physicians perceived digital health technologies as beneficial in managing CU, with 59.5% of patients and 75.3% of physicians agreeing on their advantages. However, 21.5% of patients and 14.9% of physicians remained neutral, while 8.3% of patients and 4.0% of physicians found these technologies unhelpful. Key barriers to adoption were identified, including concerns over data privacy, limitations in technical infrastructure, and a lack of awareness of available digital health solutions. CONCLUSION: While many patients and physicians recognize the potential of digital health technology to improve urticaria management, some remain uncertain or skeptical. Addressing concerns and improving digital understanding is critical to the future implementation and integration of these technologies into care. Due to the cross-sectional design of the study and the self-reported data, further research may be needed to confirm these results.
背景:慢性荨麻疹(CU)是一种复杂且难以预测的皮肤疾病,严重影响患者的生活质量。随着医疗保健领域越来越多地整合数字健康技术,从患者和医生的角度了解它们在CU管理中的感知有用性至关重要。 目的:本研究调查了CU患者及其医疗服务提供者对使用数字健康服务(如医疗应用程序和视频咨询)的接受程度、感知有用性和潜在障碍。 方法:在多个专科中心、专科诊所和全科诊所对患者和医生进行了定量调查。该研究使用标准化问卷来评估数字健康素养、技术准备情况以及对在CU管理中采用数字健康服务的态度。采用描述性和推断性统计方法,包括费舍尔精确检验,对数据进行分析。 结果:在121名接受调查的患者和101名医生中,相当一部分人认为数字健康技术对管理CU有益,59.5%的患者和75.3%的医生认同其优势。然而,21.5%的患者和14.9%的医生保持中立,而8.3%的患者和4.0%的医生认为这些技术没有帮助。确定了采用的主要障碍,包括对数据隐私的担忧、技术基础设施的限制以及对可用数字健康解决方案的缺乏认识。 结论:虽然许多患者和医生认识到数字健康技术在改善荨麻疹管理方面的潜力,但仍有一些人不确定或持怀疑态度。解决这些担忧并提高数字理解能力对于这些技术未来在医疗护理中的实施和整合至关重要。由于本研究的横断面设计和自我报告的数据,可能需要进一步的研究来证实这些结果。
J Dtsch Dermatol Ges. 2025-1
Transl Behav Med. 2025-1-16
J Dtsch Dermatol Ges. 2025-1
J Eur Acad Dermatol Venereol. 2024-11
Commun Med (Lond). 2024-1-5